INTELLIPHARMACEUTICS INTERNATIONAL INC. Accrued Liabilities, Current
INTELLIPHARMACEUTICS INTERNATIONAL INC. had Accrued Liabilities, Current of $3.52 million as of 2023-08-31, per its 6-K filed 2023-10-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2024-02-06
- 2018-11-30: Accrued Liabilities, Current 353.15K CAD.
- 2017-11-30: Accrued Liabilities, Current 782.37K CAD.
- 2017-05-31: Accrued Liabilities, Current 516.22K CAD.
- 2017-02-28: Accrued Liabilities, Current 624.83K CAD.
CAD
| Period end | Accrued Liabilities, Current |
|---|---|
| 2018-11-30 | 353.15K CAD 20-F · filed 2019-03-04 |
| 2017-11-30 | 782.37K CAD 20-F · filed 2019-03-04 |
| 2017-05-31 | 516.22K CAD 6-K · filed 2017-07-11 |
| 2017-02-28 | 624.83K CAD 6-K · filed 2017-04-12 |
| 2016-11-30 | 384.89K CAD 20-F · filed 2018-03-01 |
| 2015-11-30 | 454.29K CAD 20-F · filed 2017-02-28 |
USD
| Period end | Accrued Liabilities, Current |
|---|---|
| 2023-08-31 | $3.52M 6-K · filed 2023-10-16 |
| 2023-05-31 | $3.28M 6-K · filed 2023-09-26 |
| 2022-11-30 | $2.82M 20-F/A · filed 2024-02-06 |
| 2021-11-30 | $2.27M 20-F/A · filed 2024-02-06 |
| 2021-08-31 | $1.86M 6-K · filed 2021-10-15 |
| 2021-05-31 | $1.87M 6-K · filed 2021-07-15 |
| 2021-02-28 | $1.75M 6-K · filed 2021-04-14 |
| 2020-11-30 | $1.78M 20-F/A · filed 2022-05-09 |
| 2020-08-31 | $1.64M 6-K · filed 2020-10-15 |
| 2020-05-31 | $1.51M 6-K · filed 2020-07-15 |
| 2020-02-29 | $1.14M 6-K · filed 2020-05-29 |
| 2019-11-30 | $927.70K 20-F · filed 2021-03-31 |
| 2019-08-31 | $1.17M 6-K · filed 2019-10-11 |
| 2019-05-31 | $932.02K 6-K · filed 2019-07-10 |
| 2019-02-28 | $875.59K 6-K · filed 2019-04-15 |
| 2018-11-30 | $353.15K 20-F · filed 2020-03-30 |
| 2018-08-31 | $741.88K 6-K · filed 2018-10-15 |
| 2018-05-31 | $708.58K 6-K · filed 2018-07-24 |
| 2017-11-30 | $782.37K 6-K · filed 2018-10-15 |
| 2015-11-30 | $454.29K 20-F · filed 2016-03-21 |
| 2014-11-30 | $675.49K 20-F · filed 2016-03-21 |
| 2014-02-28 | $616.03K 6-K · filed 2014-04-14 |
| 2013-11-30 | $669.32K 20-F · filed 2015-02-27 |
| 2012-11-30 | $224.80K 20-F · filed 2014-02-18 |
| 2011-11-30 | $436.15K 20-F/A · filed 2013-02-01 |
| 2010-11-30 | $321.03K 20-F · filed 2012-05-11 |